Skip to main content
logo
Borregaard ASA (OSL:BRG)
Norway flag Norway · Delayed Price · Currency is NOK
176.20
-3.20 (-1.78%)
Feb 23, 2026, 4:29 PM CET

Revenue

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
BioSolutions Revenue
4.40B4.24B
BioSolutions Revenue Growth
3.65%7.53%
BioMaterials Revenue
2.69B2.62B
BioMaterials Revenue Growth
2.63%7.50%
Fine Chemicals Revenue
670.00M799.00M
Fine Chemicals Revenue Growth
-16.14%1.65%
Eliminations From Revenue
-44.00M-45.00M

Revenue by Geography

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Norway Revenue
227.00M
Norway Revenue Growth
-18.64%
Rest of Europe Revenue
3.25B
Rest of Europe Revenue Growth
5.07%
Asia Revenue
1.72B
Asia Revenue Growth
1.24%
America Revenue
2.24B
America Revenue Growth
18.44%
Rest of World Revenue
60.00M
Rest of World Revenue Growth
5.26%
Other Operating Revenue
115.00M
Other Operating Revenue Growth
6.48%

EBITDA

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
BioSolutions EBITDA
1.21B1.10B
BioSolutions EBITDA Growth
9.51%20.66%
BioMaterials EBITDA
495.00M434.00M
BioMaterials EBITDA Growth
14.06%-18.73%
Fine Chemicals EBITDA
174.00M336.00M
Fine Chemicals EBITDA Growth
-48.21%1.21%

EBIT

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
BioSolutions Operating Profit
896.00M791.00M
BioSolutions Operating Profit Growth
13.27%18.59%
BioMaterials Operating Profit
263.00M200.00M
BioMaterials Operating Profit Growth
31.50%-40.12%
Fine Chemicals Operating Profit
128.00M292.00M
Fine Chemicals Operating Profit Growth
-56.16%0.69%

Key Performance Indicators

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
BioSolutions - Gross Average Sales Price per MTDS
12.03K12.05K
BioSolutions - Gross Average Sales Price per MTDS Growth
-0.15%2.48%
BioSolutions - Specialities Sales Volume (MTDS in Thousands)
91.0085.00
BioSolutions - Specialities Sales Volume (MTDS in Thousands) Growth
7.06%16.44%
BioSolutions - Contruction Sales Volume (MTDS in Thousands)
97.0097.00
BioSolutions - Contruction Sales Volume (MTDS in Thousands) Growth
--3.00%
BioSolutions - Industrial Sales Volume (MTDS in Thousands)
142.00145.00
BioSolutions - Industrial Sales Volume (MTDS in Thousands) Growth
-2.07%7.41%
BioSolutions - Total Sales Volume (MTDS in Thousands)
330.00327.00
BioSolutions - Total Sales Volume (MTDS in Thousands) Growth
0.92%6.17%
BioMaterials - Gross Average Sales Price per MT
17.68K16.34K
BioMaterials - Gross Average Sales Price per MT Growth
8.17%-1.11%
BioMaterials - Sales Volume (MT in Thousands)
146.40159.90
BioMaterials - Sales Volume (MT in Thousands) Growth
-8.44%10.81%
High Specialised % of Total Cellulose Product Sales Volume
87.00%83.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai.